| Authors: |
Bewley MA; 1 Department of Infection, Immunity and Cardiovascular Disease and.; 2 The Florey Institute for Host-Pathogen Interactions, University of Sheffield Medical School, Sheffield, United Kingdom., Budd RC; 1 Department of Infection, Immunity and Cardiovascular Disease and.; 2 The Florey Institute for Host-Pathogen Interactions, University of Sheffield Medical School, Sheffield, United Kingdom.; 3 Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Ryan E; 4 Department of Respiratory Medicine.; 5 MRC Centre for Inflammation Research, and., Cole J; 1 Department of Infection, Immunity and Cardiovascular Disease and.; 2 The Florey Institute for Host-Pathogen Interactions, University of Sheffield Medical School, Sheffield, United Kingdom.; 3 Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Collini P; 1 Department of Infection, Immunity and Cardiovascular Disease and.; 2 The Florey Institute for Host-Pathogen Interactions, University of Sheffield Medical School, Sheffield, United Kingdom.; 3 Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Marshall J; 5 MRC Centre for Inflammation Research, and.; 6 Department of Infection Medicine, University of Edinburgh, Edinburgh, United Kingdom., Kolsum U; 7 Medicines Evaluation Unit, University of Manchester, Manchester, United Kingdom.; 8 University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom., Beech G; 7 Medicines Evaluation Unit, University of Manchester, Manchester, United Kingdom.; 8 University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom., Emes RD; 9 School of Veterinary Medicine and Science and.; 10 Advanced Data Analysis Centre, University of Nottingham, United Kingdom., Tcherniaeva I; 11 Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Utrecht, the Netherlands., Berbers GAM; 11 Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Utrecht, the Netherlands., Walmsley SR; 4 Department of Respiratory Medicine.; 5 MRC Centre for Inflammation Research, and., Donaldson G; 12 National Heart and Lung Institute, Imperial College London, London, United Kingdom., Wedzicha JA; 12 National Heart and Lung Institute, Imperial College London, London, United Kingdom., Kilty I; 13 Pfizer Inc., Cambridge, Massachusetts., Rumsey W; 14 Stress and Repair Discovery Performance Unit, Respiratory Therapy Area, GSK, King of Prussia, Pennsylvania; and., Sanchez Y; 14 Stress and Repair Discovery Performance Unit, Respiratory Therapy Area, GSK, King of Prussia, Pennsylvania; and., Brightling CE; 15 Institute for Lung Health, University of Leicester, Leicester, United Kingdom., Donnelly LE; 12 National Heart and Lung Institute, Imperial College London, London, United Kingdom., Barnes PJ; 12 National Heart and Lung Institute, Imperial College London, London, United Kingdom., Singh D; 7 Medicines Evaluation Unit, University of Manchester, Manchester, United Kingdom.; 8 University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom., Whyte MKB; 4 Department of Respiratory Medicine.; 5 MRC Centre for Inflammation Research, and., Dockrell DH; 5 MRC Centre for Inflammation Research, and.; 6 Department of Infection Medicine, University of Edinburgh, Edinburgh, United Kingdom. |
